Phathom Pharmaceuticals PHAT 深 滬
已收盤 09-20 16:00:00 美东时间
18.43
-0.290
-1.55%
華盛通- 最 高19.00
- 今 開18.68
- 成交量 107.35万股
- 最 低 17.97
- 昨 收 18.72
- 總市值 10.47亿
- 52周最高 19.71
- 市盈率 靜 --
- 換手率 1.89%
- 52周最低 6.065
- 委 比 99.40%
- 總股本 5680.32万
- 歷史最高 64.54
- 量 比 0.61
- 振 幅 5.50%
- 歷史最低 5.84
- 每 手 1
- 風險率 2.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Phathom Pharmaceuticals’ V oquezna: A Rising Star in GERD Treatment Market
Analyst Joseph Stringer from Needham maintained a Buy rating on Phathom Pharmac...
08-24 00:25
Phathom Pharmaceuticals prices $130M equity offering
Phathom Pharmaceuticals (NASDAQ:PHAT) said it has priced its offering of 8.7M shares and pre-funded warrants to purchase 2.61M shares. The shares will be sold at $11.5 apiece, and the pre-funded warra...
08-19 20:19
凯雷Q2狂买拼多多(PDD.US)! 新建仓热门AI股戴尔(DELL.US)
根据美国证券交易委员会(SEC)披露，全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2024年6月30日的第二季度持仓报告(13F)。
08-14 18:45
Phathom Pharmaceuticals Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-09 23:49
快讯 | Phathom Pharmaceuticals Q2 净利润 美元指数 -9144.6万
Phathom Pharmaceuticals Q2 Net Income USD -91.446 Million
08-08 20:00
CVS Caremark Adds VOQUEZNA Tablets To National Formularies For 26M Commercially Insured Members
Now Accessible To Over 116M Commercially Covered Lives; First FDA-Approved PCAB For GERD Treatment In Over 30 Years, Says Phathom Pharmaceuticals
07-30 20:11
快讯 | phathom pharmaceuticals宣布Voquezna®（Vonoprazan）已被列入CVS Caremark的商业保险患者清单
Phathom Pharmaceuticals Announces Voquezna® (Vonoprazan) Added to CVS Caremark ...
07-30 20:00
Don't Ignore The Insider Selling In Phathom Pharmaceuticals
Anyone interested in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) should probabl...
07-19 02:31
Phathom Pharma announces Voquezna label expansion
Phathom Pharmaceuticals (NASDAQ:PHAT) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its lead product, vonoprazan, allowing its use for a medical co...
07-18 23:09
